Loading…

Evotec AG is acquiring Central Glass Germany GmbH from Central Glass Co. Ltd. for a purchase price of EUR 1. The acquisition will expand Evotec's clinical and commercial manufacturing platform for small molecule therapeutics in Halle/Westphalia, Germany.
“The contract was signed on 24 August at a purchase price of EUR 1.”rttnews.com
Summarized from public sources; check the original articles before acting on it.